Fulcrum Therapeutics, Inc.
← Back to FULC Overview

Fulcrum Therapeutics, Inc. (FULC)

Price-to-Earnings Ratio History

P/E Ratio (TTM)

-2.69

Financial Fundamentals

FULCQuarterly Data • 5Y View

Quarterly P/E

QuarterP/E Ratio
2018-03-31-8.23
2018-06-30-7.34
2018-09-30-6.37
2018-12-31-6.49
2019-03-31-2.14
2019-06-30-6.03
2019-09-30-1.78
2019-12-31-5.86
2020-03-31-3.69
2020-06-30-6.93
2020-09-30-2.83
2020-12-31-4.57
2021-03-31-5.45
2021-06-30-4.37
2021-09-30-12.37
2021-12-31-7.63
2022-03-31-9.24
2022-06-30-1.48
2022-09-30-3.89
2022-12-31-4.04
2023-03-31-1.98
2023-06-30-2.17
2023-09-30-2.85
2023-12-31-4.22
2024-03-31-5.41
2024-06-301.77
2024-09-30-2.55
2024-12-31-3.79
2025-03-31-2.57
2025-06-30-6.14
2025-09-30-7.42
2025-12-31-9.12
2026-03-31-7.67
2026-06-30-2.69

* P/E ratios are calculated using trailing twelve-month (TTM) earnings.

Fulcrum Therapeutics, Inc. (FULC) P/E Ratio History & Valuation Cycles